Wound Management Market Segments Growing in Key Product and Regional Market Areas
Globally, the market for the diverse array of products in surgical, chronic and acute wound management stands at $13 billion, with aggregate growth at 7 percent annually. Select sectors are demonstrating appreciably stronger growth including active physical stimulation, pharmaceuticals, enzymatic debriders, tissue engineering, and other active therapies for wound management. Differences geographically in the clinical management of wounds and in the adoption of new products are also creating opportunities in local markets. These data are detailed in the August 2005 report by MedMarket Diligence on the worldwide wound management market.
Products in the advanced segment of wound care, encompassing drugs, physical stimulation devices, enzymatic debridement, tissue engineered skin substitutes and others, represent areas of the greatest market growth in this arena. These technologies have emerged, generally, over the last 25 years since the introduction of the "moist healing" concept and the aggressive development by big medical device companies seeking new innovations in an increasingly competitive environment full of generic manufacturers and distributors of advanced wound management products.
The 2005 MedMarket Diligence report on wound management details the current and emerging technologies and products spanning dressings, closure devices, debridement, pharmacological products, tissue engineered products and others.
Source: MedMarket Diligence, LLC
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
Beyond the Surface: Tackling the Sterilization Challenges of Flexible Endoscopes
May 26th 2025Flexible endoscopes revolutionized modern medicine—but their complex design poses persistent sterilization challenges. With mounting infection risks and emerging innovations, experts are rethinking how to clean and safeguard one of health care’s most indispensable tools.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
